OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

Rhea-AI Summary

OptimizeRx (Nasdaq: OPRX), a leading provider of healthcare technology solutions for life sciences companies, has scheduled its Fourth Quarter and Full Year 2024 financial results conference call for March 12, 2025, at 8:30 a.m. ET. The company will release its financial results for the quarter ended December 31, 2024, via press release before the conference call. Management will host the call followed by a Q&A session. A replay will be accessible for 12 months through the Investors section of the OptimizeRx website.

News Market Reaction – OPRX

+0.59%

1 alert

+0.59% News Effect

On the day this news was published, OPRX gained 0.59%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Wednesday, March 12, 2025, at 8:30 a.m. Eastern Time to discuss full year fiscal 2024 financial results and the fourth quarter period ended December 31, 2024. The financial results will be issued in a press release prior to the call.

OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:

Date:	Wednesday, March 12, 2025
Time:	8:30 a.m. Eastern Time (5:30 a.m. Pacific Time)
Toll Free:	1-844-825-9789
International:	1-412-317-5180
Conference ID:	2202248
Call Me Link:	https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg==
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1708545&tp_key=86684771bf

Please call the conference telephone number or log on to the web access link five minutes prior to the start time.

A replay of the call will remain available for 12 months via the Investors section of the OptimizeRx website at http://www.optimizerx.com/investors.  

About OptimizeRx

OptimizeRx provides trailblazing technology that fosters care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the healthcare journey. With the ability to synchronize messaging across 2 million healthcare providers and over 240 million adults across a multitude of digital channels including a proprietary point-of-care network, OptimizeRx is changing the way life sciences engage with customers.

For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com. 

OptimizeRx Contact 
Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com

Investor Relations Contact
Sandya von der Weid
LifeSci Advisors, LLC
svonderweid@lifesciadvisors.com

FAQ

When will OptimizeRx (OPRX) release its Q4 2024 earnings?

OptimizeRx will release Q4 2024 earnings via press release before its conference call on March 12, 2025, at 8:30 a.m. ET.

How can investors access OptimizeRx's (OPRX) Q4 2024 earnings call?

Investors can join the conference call scheduled for March 12, 2025, at 8:30 a.m. ET. Participants should connect five minutes before the start time.

How long will OptimizeRx's (OPRX) Q4 2024 earnings call replay be available?

The earnings call replay will be available for 12 months through OptimizeRx's Investors website section.

What period will OptimizeRx's (OPRX) upcoming earnings report cover?

The earnings report will cover Q4 and full year 2024, with the quarter ending December 31, 2024.